Clinical Trial Update: Ranolazine in Diastolic Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ranolazine for diastolic heart failure has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Gilead Sciences | Conditions: Diastolic Heart Failure | Phase 2 | Status: COMPLETED